Interferon beta but not glatiramer acetate therapy aggravates headaches in MS

Neurology

Volumn 59, Issue 4, 2002, Pages 636-639

  Pollmann W ^a   Erasmus, L P ^a   Feneberg, W ^a   Then Bergh, F ^a   Straube, A ^a  

^a Marianne Strauss Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GLATIRAMER;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HEADACHE; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SIDE EFFECT; VISUAL ANALOG SCALE;

EID: 0037183484     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.4.636     Document Type: Article

References (10)

1. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
2. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis
3. Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
4. Evidence of interferon β-1a dose response in relapsing-remitting MS
5. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a Phase III multicenter, double-blind, placebo-controlled trial
6. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
7. Migraine induced by interferon beta therapy for multiple sclerosis
8. PRISMS-4: Long-term efficacy of interferon-β-1a in relapsing MS
9. Acute effects of interferon beta-la on plasma cytokine levels in patients with MS
10. Mechanisms of action of glatiramer acetate in multiple sclerosis